What MeVis Medical Solutions AG does

MeVis Medical Solutions AG is a Bremen, Germany-based, publicly traded (Frankfurt/XETRA, Berlin, Düsseldorf, Munich, Stuttgart; ticker M3V; ISIN DE000A0LBFE4) developer of image-based medical diagnostic software, founded in 1997 with technical roots in the 1992 CeVis initiative at the University of Bremen and the German Cancer Research Center (DKFZ). It has been listed since 2007 and is majority-owned by Varex Imaging Corporation (USA) through Varex Imaging Deutschland AG, with a control and profit transfer agreement in place subordinating the listing to the parent group. The company focuses on image-based early detection and diagnosis of breast, lung, and liver cancer as well as neurological diseases, supporting all major imaging modalities (MRI, digital mammography, CT, tomosynthesis, and ultrasound).

The product portfolio is built around the MeVisLab development platform and the MeVisAP application development platform. Application-layer products include Veolity (AI-powered lung cancer screening workflow for radiologists and national screening programs), MeVis Liver Suite (liver disease analysis), MeVis Online Academy (radiologist education via webinars and case collections), and MeVis Distant Services (MDS, remote support). The company operates an EN ISO 13485:2016-certified quality management system across EU, USA, Canada, Australia, and Taiwan under MDR, MDSAP, and related regimes.

Revenue is generated primarily through software licensing, development services, and ongoing support/maintenance sold via direct enterprise sales to medical device manufacturers and medical IT platform providers (RIS/PACS), with end users including radiologists and clinical institutions. Reported FY2024/2025 revenue was €16,061k against ~102 FTE, with an EBIT margin of 13% — down from €16,972k and 21% in FY2023/2024 — and a May 2026 forecast adjustment signaled continued near-term pressure. Marketing channels combine major industry congresses (RSNA, ECR, ESTI, RÖKO, ILTS, WCLC), the MeVis Online Academy, the corporate website, and LinkedIn/XING.

Name

MeVis Medical Solutions AG

Legal name

MeVis Medical Solutions AG

Website

https://mevis.de

Company type

Public

Founded year

1997

Operating status

Operating

Headcount range

51–100 employees

Short description

MeVis Medical Solutions AG is a Bremen-based, publicly traded medical imaging software company majority-owned by Varex Imaging Corporation, developing AI-assisted diagnostic software (Veolity lung cancer screening, MeVis Liver Suite, MeVisLab platform) licensed to medical device manufacturers and healthcare IT platform providers globally.

Ownership category

akta.pro rank

Product category

Medical Imaging Software

NAICS

Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Custom Computer Programming Services (541511)

SIC

Laboratory Analytical Instruments (3826)

akta.pro primary industry

AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG)

Keywords

• Medical imaging software
• Lung cancer screening
• Liver diagnostics software
• Radiology software solutions
• Clinical image analysis

Headquarters

HQ city

Bremen

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Software Licenses and Applications: MeVis develops and markets innovative software for analysis and evaluation of medical image data to manufacturers of medical products and providers of medical IT platforms. Revenue is generated through software licensing, development services, and ongoing support/maintenance.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Core offering

MeVis Medical Solutions AG develops and markets specialized software for the analysis and evaluation of medical image data, supporting image-based early detection and diagnosis of breast, lung, and liver cancer as well as neurological diseases. The company sells its software products (including Veolity lung cancer screening, MeVis Liver Suite, and the MeVisLab platform) to manufacturers of medical devices and providers of medical IT platforms, with full-service support from product concept and application development through integration into customer platforms and ongoing quality assurance.

Product overview

MeVis Medical Solutions AG offers a portfolio of medical imaging software solutions comprising its core products Veolity (lung cancer screening with AI), MeVis Liver Suite (liver diagnostics), and MeVisLab (development platform). These are complemented by professional services including MeVis Online Academy (radiology education via webinars and case collections) and MeVis Distant Services (remote support). The company focuses on image-based early detection and diagnosis of epidemiologically significant diseases including breast cancer, lung cancer, liver cancer, and neurological diseases, supporting all major imaging modalities (MRI, digital mammography, CT, tomosynthesis, and ultrasound).

Differentiator

Problem solved

Functional benefit

Brands

• MeVisLab: Software platform for medical image processing and visualization.
• MeVis Online Academy
• MeVis Distant Services (MDS)
• MeVis Liver Suite
• Veolity
• MeVisAP

Products and services

• Veolity Comprehensive lung cancer screening software solution that supports radiologists, screening centers, and national screening initiatives at every stage of the diagnostic workflow using AI-powered analysis for lung nodule management.
• MeVis Liver Suite Specialized software suite for liver disease diagnosis and analysis that supports surgeons and medical professionals in liver-related imaging workflows.
• MeVisLab Proprietary development environment and technical competence platform providing tools for visualizing and processing imaging data from medical to industrial applications, including a Path Tracer for photorealistic renderings.
• MeVis Online Academy Webinar and case collection platform for radiologists offering educational content and professional development resources, including COVID-19 case collections.
• MeVis Distant Services (MDS) Remote professional services offering support and assistance for medical imaging software users, enabling off-site expert help with MeVis applications.
• MeVisAP Technical competence platform for application development and integration of MeVis software components into customer-specific medical imaging platforms.

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature6 records

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Carestream Health: Carestream offers Vue PACS, Clinical Collaboration Platform, and image-processing software serving hospitals and OEMs. Comparable to MeVis as an enterprise imaging software vendor with diagnostic visualization and clinical workflow capabilities, though with broader portfolio and focus on larger enterprise customers.
• GE HealthCare: GE HealthCare's Edison platform and AW workstation provide advanced visualization and AI applications for radiology including lung and liver analysis. Comparable to MeVis's enterprise imaging analytics offering; GE's CEO of MeVis (Marcus Kirchhoff) previously led GE Healthcare IT Central Europe sales, illustrating the close industry overlap.
• Siemens Healthineers (syngo.via): Siemens Healthineers' syngo.via and AI-Rad Companion platforms provide post-processing and AI-assisted reading for CT, MR, and mammography — including lung, liver, and breast analysis. Comparable to MeVis's Veolity, MeVis Liver Suite, and breast imaging capabilities, but with broader modality coverage and embedded OEM relationships with Siemens imaging hardware.
• Philips (IntelliSpace Portal): Philips offers enterprise imaging software including IntelliSpace Portal with lung cancer screening and AI-powered diagnostic modules. Directly comparable to MeVis in providing AI-driven analysis of CT/MR for lung and other disease areas, though as part of a much larger imaging and patient care portfolio serving global OEMs and providers.
• FUJIFILM Healthcare (Synapse): FUJIFILM's Synapse PACS and AI-enabled radiology offerings target similar hospital and OEM customers as MeVis. Comparable in providing image visualization and analysis software across modalities, including lung and breast screening applications, though at substantially larger scale and as part of a broader imaging hardware portfolio.

Emerging players

• Lunit: Lunit develops AI-powered medical image analysis, most notably Lunit INSIGHT for chest X-ray and mammography — directly competing with Veolity and MeVis's breast imaging capabilities. Comparable AI-first architecture with cloud-native deployment; smaller scale than MeVis but rapidly growing and well-funded.
• Riverain Technologies (ClearRead): Riverain Technologies offers ClearRead AI tools for chest CT and X-ray interpretation, including lung nodule and suppression technology. Comparable to Veolity in the lung cancer screening workflow niche; smaller scale and focused product line.
• Optellum: Optellum's Virtual Nodule Clinic and Lung Cancer Screening AI directly target the same clinical use case as MeVis's Veolity — lung nodule management and lung cancer risk prediction. Most direct emerging-AI competitor; FDA-cleared and CE-marked, with focused go-to-market in screening programmes.
• Aidoc: Aidoc provides AI orchestration and triage solutions for radiology workflows across multiple modalities. Comparable to MeVis in providing AI-driven imaging analytics integrated into PACS/RIS workflows, but with a broader triage and acute-care focus versus MeVis's disease-specialized screening approach.

Direct peers

• Agfa HealthCare (Enterprise Imaging): Agfa HealthCare's Enterprise Imaging platform integrates RIS/PACS with advanced visualization and AI-driven diagnostic workflows for radiology. Comparable to MeVis in providing image-based diagnostic applications to hospitals and IT platform providers, with similar focus on workflow integration and clinical specialty modules.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xxing.com/companies/mevismedicalsolutionsag
• LinkedInlinkedin.com/company/813727

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MeVis Medical Solutions AG